Lantus solostar and Xeroderma - a phase IV clinical study of FDA data

Summary:

We study 42,077 people who take Lantus solostar (insulin glargine recombinant) or have Xeroderma. No report of Xeroderma is found in people who take Lantus solostar.

The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.

What is Lantus Solostar?

Lantus solostar has active ingredients of insulin glargine recombinant. It is often used in diabetes. eHealthMe is studying from 41,639 Lantus solostar users. Check the latest studies of Lantus solostar.

What is Xeroderma?

Xeroderma (dry skin include itching and red, cracked or flaky skin) is found to be associated with 44 drugs and 291 conditions by eHealthMe. Check the latest studies of Xeroderma.

On Jul, 03, 2026

No report is found.

Do you take Lantus solostar and have Xeroderma?

- Check whether Xeroderma is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lantus solostar:

Lantus solostar (41,639 reports)

Xeroderma treatments and more:

Xeroderma (438 reports)

How severe was Xeroderma and when was it recovered:

Xeroderma in Lantus solostar

Expand to all the drugs that have ingredients of insulin glargine recombinant:

Xeroderma and drugs with ingredients of insulin glargine recombinant

Browse all side effects of Lantus solostar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Xeroderma:

Xeroderma

Browse all the conditions that are associated with Xeroderma:

Xeroderma

How the study uses the data?

The study uses data from the FDA. It is based on insulin glargine recombinant (the active ingredients of Lantus solostar) and Lantus solostar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.